India is importing monoclonal antibodies from Australia to treat Nipah virus infection in Kerala. The drug, m102.4, was initially developed for treating Henipavirus. Early-stage trials have shown its potential in managing NiV, which has a high mortality rate of 40-70%.
India sources antibodies from Australia to fight Nipah virus
September 15, 2023
0
Tags
